Tata Capital Healthcare Fund II (“TCHF”) has invested approximately ₹82.6 crores ($10 million) in Cellcure Cancer Centre Private Limited.
Pioneer Legal acted for TCHF in this deal and assisted in the following ways:
Assisting in conducting the legal due diligence on Cellcure and its
group entities.
Assisting in drafting, reviewing, revising and finalising the Investment Agreement, and disclosure letters.
Assisting in other general advisory and closing related aspects of the transaction.
The transaction team consisted of Mayank Mehta (Partner), Adwait Munje (Senior Associate), Niyati Khullar (Associate) and Rutvik Shukla (Associate)
AZB & Partners acted for Cellcure and its founders in this deal.
If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.